Quang X. Pham - 18 Jan 2024 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Matthew K. Szot, Attorney-in-fact
Issuer symbol
CVKD
Transactions as of
18 Jan 2024
Net transactions value
$0
Form type
4
Filing time
19 Jan 2024, 19:40:20 UTC
Previous filing
12 Feb 2024
Next filing
10 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock Options Award $0 +150,000 $0.000000 150,000 18 Jan 2024 Common Stock 150,000 $0.9400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.